Independent and not affiliated with the FDA, MHRA, ISPE, PDA, or any agency. Get the appgoutham@madhadi.com
madhadi.comData Integrity & GxP Quality
Browse all topics → Articles Templates & Procedures Learning paths GlossaryScenariosToolsRegulatory ReferencesLearning PathsTopics About Start here
SOP Plug-and-play starting point Sterility & Microbiology

SOP: Pharmaceutical Water System Sampling, Monitoring, and Excursion Response

A plug-and-play SOP for routine water system monitoring: sample-point preparation and technique, the conductivity/TOC/microbial/endotoxin program, alert and action levels, trending, and the graded excursion response with product-impact assessment, with a filled specimen.

Document type: SOP

Read and copy the template below into your own quality system. It is a generic starting point for your own internal use, provided as is, with no warranty; see the Terms and License. Adopting it does not by itself create compliance.

This is a ready-to-use SOP for the routine monitoring of a qualified pharmaceutical water system: how to sample, what to test, how alert and action levels work, and exactly what to do when a result exceeds them. Replace every <<FILL: ...>> placeholder, set your document numbers and dates, and route it through document control and approval. A worked filled specimen follows. Verify each cited regulation and compendial chapter against the current source. This is general guidance to adapt, not legal or regulatory advice.

Document control header

FieldEntry
Document titleWater System Sampling, Monitoring, and Excursion Response
Document number<<FILL: SOP-ID, e.g. SOP-QC-088>>
Version<<FILL: 1.0>>
Effective date<<FILL: effective date>>
Supersedes<<FILL: prior version or "New">>
Document owner<<FILL: role, e.g. Head of QC Microbiology>>
Applies to<<FILL: system(s) / grade(s)>>

1. Purpose

To define how <<FILL: COMPANY NAME>> routinely samples and monitors its qualified <<FILL: PW/WFI>> system for chemical and microbial quality, trends the results, and responds to excursions so that water is only used when its quality is demonstrated and any impact on product is assessed.

2. Scope

Routine monitoring of the qualified system after Phase 3, at every point of use plus the tank and return, for conductivity, TOC, microbial count, and (WFI) endotoxin. It does not cover the three-phase performance qualification (see the paired PQ protocol) or the engineering maintenance of the loop.

3. Responsibilities

RoleResponsibility
QC samplerPrepares the sample point, samples aseptically, records the sample, delivers it promptly.
QC Microbiology / ChemistryTests, reads, and records results; trends against alert/action levels.
Engineering / System ownerExecutes sanitization, maintains the loop and analyzers.
QAReviews trends, dispositions excursions, decides on water release/hold, owns deviation and CAPA.

4. Definitions

  • Alert level: a site-set, data-derived early-warning value below the action level; exceeding it triggers a trend investigation.
  • Action level: the value (at or below the compendial guidance) whose exceedance triggers a deviation and product-impact assessment.
  • Grab sample: a discrete manual sample from a point of use, taken the way the water is used.

5. Procedure

5.1 Sample-point preparation and technique

  1. Sanitize the sample valve per the method (for example flame or sanitizing wipe as specified for the valve type).
  2. Flush only as production flushes; if production draws without flushing, sample without a long flush, so the sample reflects the water actually used.
  3. Collect into the correct sterile container for microbial testing and the correct container for chemical testing, using aseptic technique.
  4. Label with point ID, date, time, and sampler.

5.2 What to test and how

  1. Conductivity: read online (Stage 1, temperature-compensated) at the generation outlet and loop return; grab measurement at points of use as specified.
  2. TOC: read online where available; otherwise grab per <643>.
  3. Microbial: membrane filtration for WFI (large volume) or plate for PW, low-nutrient agar (e.g. R2A), extended incubation at a lower temperature per the validated recovery method.
  4. Endotoxin (WFI): USP <85> LAL method.
  5. Test microbial samples promptly or hold cold; counts change on standing.

5.3 Frequency

Follow the routine frequency established by the Phase 3 data, recorded in Attachment A. <<FILL: e.g. each POU on a defined rotation; online conductivity/TOC continuous>>.

  1. Trend every attribute per point of use.
  2. Look at the slope, not only the value: a TOC or microbial count creeping up while still in-control is investigated before it reaches the action level.
  3. A rising TOC with stable conductivity is treated as a possible early biofilm signal.

5.5 Excursion response (graded)

SituationResponse
Below alertRecord and trend
At/above alert, below actionInvestigate the trend: adjacent points, time since sanitization, recent changes; no product-impact assessment unless the trend is adverse
At/above actionRaise a deviation; assess impact on every batch using water from this point since the last in-control result; identify the organism (microbial); review sanitization; decide whether to sanitize and resample before further use
Conductivity/TOC out of compendial limitTreat as a specification failure: confirm the instrument, run the staged <645> evaluation if conductivity, quarantine affected water, deviation with impact assessment

QA decides water hold/release on the basis of the impact assessment.

6. Acceptance criteria

  • Samples are taken by the defined technique, the way the water is used, and tested by validated methods.
  • Results are trended per point; adverse trends below action level are investigated.
  • Every action-level exceedance and every compendial out-of-limit has a deviation with a product-impact assessment before affected water is used.
  • Alert/action levels are current and derived from real data.

7. References

USP <1231>; the PW and WFI monographs; <645> Water Conductivity; <643> Total Organic Carbon; <85> Bacterial Endotoxins Test. European Pharmacopoeia PW and WFI monographs. EU GMP Annex 1 (2022) contamination control strategy. 21 CFR 211.48, Part 211; FDA Guide to Inspections of High Purity Water Systems.

Confirm the current version of each reference and chapter before issue.

8. Record generated: excursion record

FieldEntry
Point / attribute<<FILL>>
Result vs alert/action<<FILL>>
Level exceededAlert / Action / Compendial
Batches using this water since last good result<<FILL>>
Organism ID (microbial)<<FILL>>
Sanitization action<<FILL>>
Product-impact assessment<<FILL>>
Deviation reference<<FILL>>
QA disposition<<FILL>>

9. Revision history

VersionDateAuthorSummary of change
<<FILL: 1.0>><<FILL: date>><<FILL: author>>Initial issue.

10. Approvals

RoleNameSignatureDate
Author<<FILL>>
Reviewer (QA)<<FILL>>
Approver (Quality Head)<<FILL>>

Filled specimen

An illustrative excursion record for a WFI point of use.

FieldEntry
Point / attributePOU-07, microbial
Result vs alert/action14 CFU/100 mL vs alert 3, action 10
Level exceededAction
Batches using this water since last good resultTwo lots (LOT-2280, LOT-2281)
Organism ID (microbial)Gram-negative rod, identified to genus
Sanitization actionLoop thermally sanitized, POU-07 resampled
Product-impact assessmentTwo lots assessed; water use was final rinse only; endotoxin on both lots within limit; no adverse impact concluded
Deviation referenceDEV-2026-0163
QA dispositionPoint returned to use after two consecutive in-control resamples; lots released with documented rationale

Here the action-level exceedance triggered exactly the right chain: deviation, organism ID, impact assessment on the specific lots that used the water, sanitization, resample, and a QA disposition, rather than a quiet reset.

Common inspection findings this SOP prevents

  • A microbial action-level exceedance with no impact assessment on product made since the last clean result.
  • Sampling after a long flush when production does not flush, validating cleaner water than is used.
  • Rising microbial or TOC trends below action level, treated as “in spec” and never investigated.
  • No organism identification and no link to sanitization after an excursion.

How to adapt this SOP

  1. Set your document number, owner, and the systems/grades in scope.
  2. Insert the real routine frequency and alert levels from your Phase 3 data in Attachment A and section 5.4.
  3. Specify your valve-sanitization technique and container types.
  4. Point the excursion response to your real deviation, CAPA, and sanitization procedures.
  5. Confirm every compendial chapter and regulation against the current published version before issue.
Use madhadi.com as an app Full screen, works offline, one tap from your home screen.